Published in J Biol Chem on November 08, 2016
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06
The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer (2007) 9.81
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (1992) 7.68
Recurrent gene fusions in prostate cancer. Nat Rev Cancer (2008) 6.08
The ETS-domain transcription factor family. Nat Rev Mol Cell Biol (2001) 6.01
How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol (2003) 4.90
The Ets family of transcription factors. Eur J Biochem (1993) 4.74
Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell (2003) 4.67
Global protein stability profiling in mammalian cells. Science (2008) 3.91
Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev (1992) 3.69
ETS transcription factors and their emerging roles in human cancer. Eur J Cancer (2005) 3.55
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1995) 3.38
EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol (2004) 3.33
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell (2006) 3.29
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene (2005) 3.13
Global identification of modular cullin-RING ligase substrates. Cell (2011) 3.13
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A (1993) 3.07
Ewing's sarcoma family of tumors: current management. Oncologist (2006) 2.97
Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem (2011) 2.89
The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol (1993) 2.84
Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol (2008) 2.57
Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science (2008) 2.53
Dynamics of heat shock factor association with native gene loci in living cells. Nature (2006) 2.45
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res (2008) 2.39
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol (1994) 2.18
Regulation of Ets function by protein - protein interactions. Oncogene (2000) 1.93
COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature (2011) 1.83
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res (2006) 1.80
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res (2001) 1.75
Keeping transcriptional activators under control. Cell (2006) 1.62
EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest (1997) 1.61
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res (2006) 1.57
The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol (2001) 1.57
Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol (1995) 1.47
Translocation-related sarcomas. Semin Oncol (2009) 1.45
Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene (1998) 1.41
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ (1996) 1.40
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Cancer Res (2006) 1.32
SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. Mol Cell (2015) 1.25
Molecular phylogeny of the ETS gene family. Oncogene (1999) 1.24
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene (2012) 1.20
Solution structure of the ets domain of Fli-1 when bound to DNA. Nat Struct Biol (1994) 1.20
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation. Mol Cell (2015) 1.17
EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. Cancer Res (2009) 1.17
Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene (2006) 1.06
DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J Biol Chem (2001) 1.05
STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol Cancer Res (2011) 1.02
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma. Int J Cancer (2012) 1.01
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proc Natl Acad Sci U S A (2015) 0.99
Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides. J Neurooncol (1997) 0.98
The Colossus of ubiquitylation: decrypting a cellular code. Mol Cell (2013) 0.96
O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. Oncogene (2009) 0.95
The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors. Cancer Res (2006) 0.95
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J Clin Invest (2014) 0.90
Ubiquitin-Dependent Turnover of MYC Antagonizes MYC/PAF1C Complex Accumulation to Drive Transcriptional Elongation. Mol Cell (2015) 0.87
Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage. Biochem J (2009) 0.85
Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity. Front Oncol (2012) 0.82
Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover. J Proteome Res (2014) 0.81
Targeting transcription factors by small compounds-Current strategies and future implications. Biochem Pharmacol (2015) 0.77